Global Patient Safety LeadargenxGhent, Oost-Vlaanderen, Belgium
PB1334 - Safety Profile of Efgartigimod from Clinical Trials in Participants with Immunoglobulin G-Mediated Autoimmune Diseases
Tuesday, June 27, 202318:30 – 19:30 ET